FDA.reportPublic FDA data

acetaminophen 194 MG / aspirin 227 MG / caffeine 33 MG Oral Tablet [Vanquish]

RxCUI
1101754
RxNorm name
acetaminophen 194 MG / aspirin 227 MG / caffeine 33 MG Oral Tablet [Vanquish]
Display name
VANQUISH (Oral Pill)
Full name
acetaminophen 194 MG / aspirin 227 MG / caffeine 33 MG Oral Tablet [Vanquish]
Term type
SBD
Status
Active
Strength
194-227-33 mg
Dose form
Tab
Route
Oral Pill
Updated
2026-07-17 21:40:19

RxNorm Status History#

Status
Active
Source
RXNORM
Current
YES
Release start
062011
Active start
062011
Multiple ingredient
YES
Branded
YES

Ingredients And Strength#

Ingredient, Strength, Base table
IngredientStrengthBaseBasis of strength
aspirin227 MG / 1 EACHaspirinaspirin
acetaminophen194 MG / 1 EACHacetaminophenacetaminophen
caffeine33 MG / 1 EACHcaffeinecaffeine

Dose Form Concepts#

Dose form, RxCUI table
Dose formRxCUI
Oral Tablet317541

Derived Ingredient Concepts#

Ingredient, RxCUI table
IngredientRxCUI
aspirin1191
acetaminophen161
caffeine1886

Source Vocabulary Codes#

Code type, Value, Category table
Code typeValueCategory
PRESCRIBABLEYATTRIBUTES
RXNAV_STRAPAP 194 MG / ASA 227 MG / Caffeine 33 MG Oral Tablet [Vanquish]NAMES
RxNorm Nameacetaminophen 194 MG / aspirin 227 MG / caffeine 33 MG Oral Tablet [Vanquish]NAMES
RxNorm SynonymAPAP 194 MG / ASA 227 MG / Caffeine 33 MG Oral Tablet [Vanquish]NAMES
RxNorm SynonymVanquish (APAP 194 MG / ASA 227 MG / caffeine 33 MG) Oral TabletNAMES
TTYSBDATTRIBUTES
SPL_SET_IDf879e8c7-1983-4a85-b87d-38f5068351fcCODES
RxCUI1101754CODES
MMSL_CODEBD36925CODES
MMSL_CODEBD4578CODES

FDA NDC Products And Packages#

Package NDC, Product NDC, Name table
Package NDCProduct NDCNameLabelerApplication
42364-0011-142364-0011vanquish acetaminophen, aspirin, and caffeineDSE Healthcare Solutions, LLCM013
42364-0011-242364-0011vanquish acetaminophen, aspirin, and caffeineDSE Healthcare Solutions, LLCM013

Drugs@FDA Applications#

Application, NDC, Name table
ApplicationNDCNameMarketing categoryLabeler
M01342364-0011vanquish acetaminophen, aspirin, and caffeineOTC MONOGRAPH DRUGDSE Healthcare Solutions, LLC

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 13 matching rows.

NDC11, Source, Active table
NDC11SourceActive
12843017148rxnav_ndcsyes
42364001101rxnav_ndcsyes
42364001102rxnav_ndcsyes
59556015110rxnav_ndcsyes
12843017144rxnav_historical
12843017146rxnav_historical
16864020101rxnav_historical
16864020102rxnav_historical
42364012203rxnav_historical
42364012206rxnav_historical
59556081006rxnav_historical
59556081011rxnav_historical
89411012201rxnav_historical

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
vanquishACETAMINOPHEN, ASPIRIN, AND CAFFEINEDSE Healthcare Solutions, LLCf879e8c7-1983-4a85-b87d-38f5068351fc2024-12-18WarningsExact identifier
ndc (package): 42364-0011-1
ndc (package): 42364-0011-2
ndc (product): 42364-0011
ndc11 (package): 42364001102
ndc11 (package): 42364001101
rxcui: 1101754

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
f879e8c7-1983-4a85-b87d-38f5068351fcVanquish (APAP 194 MG / ASA 227 MG / caffeine 33 MG) Oral TabletSY6Vanquish Drug Facts20241218
f879e8c7-1983-4a85-b87d-38f5068351fcAPAP 194 MG / ASA 227 MG / Caffeine 33 MG Oral Tablet [Vanquish]SY6Vanquish Drug Facts20241218
f879e8c7-1983-4a85-b87d-38f5068351fcVanquish 227 MG / 194 MG / 33 MG Oral TabletPSN6Vanquish Drug Facts20241218
f879e8c7-1983-4a85-b87d-38f5068351fcacetaminophen 194 MG / aspirin 227 MG / caffeine 33 MG Oral Tablet [Vanquish]SBD6Vanquish Drug Facts20241218

DailyMed Labels#

Set ID, Title, Manufacturer table
Set IDTitleManufacturerEffective
f879e8c7-1983-4a85-b87d-38f5068351fcVanquish Drug FactsDSE Healthcare Solutions, LLC20241218
3bad642b-a65c-4d9b-add7-846c23e8dcdcVanquish Digital Headache Drug FactsDSE Healthcare Solutions, LLC | Contract Pharmacal Corporation20201211
6511491e-2721-4ec8-bf4a-c36ebfd4a92aVanquish Drug FactsStrides Pharma Inc | Strides Pharma Global Pte. Ltd. | Contract Pharmacal Corporation20191226

Drug Classes#

Source, Class ID, Class table
SourceClass IDClassTypeRelationshipDrug concept
ATCN02BEAnilidesATC1-4acetaminophen
ATCA01ADOther agents for local oral treatmentATC1-4aspirin
ATCD11AXOther dermatologicalsATC1-4caffeine
ATCB01ACPlatelet aggregation inhibitors excl. heparinATC1-4aspirin
ATCN02BASalicylic acid and derivativesATC1-4aspirin
ATCN06BCXanthine derivativesATC1-4caffeine
FDASPLD014970XanthinesCHEMhas_chemical_structurecaffeine
FDASPLN0000175739Central Nervous System StimulantEPChas_epccaffeine
FDASPLN0000175790MethylxanthineEPChas_epccaffeine
FDASPLN0000175722Nonsteroidal Anti-inflammatory DrugEPChas_epcaspirin
FDASPLN0000175578Platelet Aggregation InhibitorEPChas_epcaspirin
FDASPLN0000175729Central Nervous System StimulationPEhas_pecaffeine
MEDRTD000082AcetaminophenCHEMhas_ingredientacetaminophen
MEDRTD001241AspirinCHEMhas_ingredientaspirin
MEDRTD002110CaffeineCHEMhas_ingredientcaffeine
MEDRTD001049ApneaDISEASEmay_treatcaffeine
MEDRTD001172Arthritis, RheumatoidDISEASEmay_treataspirin
MEDRTD001778Blood Coagulation DisordersDISEASEci_withaspirin
MEDRTD001791Blood Platelet DisordersDISEASEci_withaspirin
MEDRTD002544Cerebral InfarctionDISEASEmay_preventaspirin
MEDRTD002644ChickenpoxDISEASEci_withaspirin
MEDRTD002675Child, PreschoolDISEASEci_withaspirin
MEDRTD004342Drug HypersensitivityDISEASEci_withacetaminophen
MEDRTD004342Drug HypersensitivityDISEASEci_withaspirin
MEDRTD004342Drug HypersensitivityDISEASEci_withcaffeine
MEDRTD005221FatigueDISEASEmay_treatcaffeine
MEDRTD005334FeverDISEASEmay_preventacetaminophen
MEDRTD005334FeverDISEASEmay_treataspirin
MEDRTD005334FeverDISEASEmay_treatacetaminophen
MEDRTD005955Glucosephosphate Dehydrogenase DeficiencyDISEASEci_withacetaminophen
MEDRTD006073GoutDISEASEmay_treataspirin
MEDRTD006396HematemesisDISEASEci_withaspirin
MEDRTD006474Hemorrhagic DisordersDISEASEci_withaspirin
MEDRTD007223InfantDISEASEci_withaspirin
MEDRTD007249InflammationDISEASEmay_treataspirin
MEDRTD002546Ischemic Attack, TransientDISEASEmay_preventaspirin
MEDRTD008107Liver DiseasesDISEASEci_withacetaminophen
MEDRTD008551MelenaDISEASEci_withaspirin
MEDRTD009203Myocardial InfarctionDISEASEmay_preventaspirin
MEDRTD009298Nasal PolypsDISEASEci_withaspirin
MEDRTD010003OsteoarthritisDISEASEmay_treataspirin
MEDRTD010146PainDISEASEmay_treataspirin
MEDRTD010146PainDISEASEmay_preventacetaminophen
MEDRTD010146PainDISEASEmay_treatacetaminophen
MEDRTD010146PainDISEASEmay_preventaspirin
MEDRTD011225Pre-EclampsiaDISEASEmay_preventaspirin
MEDRTD011263Pregnancy Trimester, ThirdDISEASEci_withaspirin
MEDRTD012213Rheumatic FeverDISEASEmay_treataspirin
MEDRTN0000000160Cyclooxygenase InhibitorsMOAhas_moaaspirin
MEDRTN0000000133Enzyme InhibitorsMOAhas_moacaffeine
MEDRTN0000000108Prostaglandin Receptor AntagonistsMOAhas_moaacetaminophen
MEDRTN0000008322BronchodilationPEhas_pecaffeine
MEDRTN0000008331Cardiovascular Activity AlterationPEhas_pecaffeine
MEDRTN0000175724Central Nervous System Activity AlterationPEhas_peacetaminophen
MEDRTN0000008567Decreased Collecting Duct Water PermeabilityPEhas_pecaffeine
MEDRTN0000008831Decreased Platelet Activating Factor ProductionPEhas_peaspirin
MEDRTN0000008832Decreased Platelet AggregationPEhas_peaspirin
MEDRTN0000008836Decreased Prostaglandin ProductionPEhas_peaspirin
MEDRTN0000008836Decreased Prostaglandin ProductionPEhas_peacetaminophen
MEDRTN0000009006Decreased Thromboxane ProductionPEhas_peaspirin
MEDRTN0000009072Hypothalamic Endocrine Activity AlterationPEhas_peacetaminophen
MEDRTN0000009197Increased Central Nervous System Organized Electrical ActivityPEhas_pecaffeine
MEDRTN0000175725Peripheral Nervous System Activity AlterationPEhas_peacetaminophen
MEDRTN0000000026Hepatic MetabolismPKhas_pkaspirin
MEDRTN0000000026Hepatic MetabolismPKhas_pkacetaminophen
MEDRTN0000000042Renal ExcretionPKhas_pkaspirin
MEDRTN0000000042Renal ExcretionPKhas_pkacetaminophen

Properties#

Category, Property, Value table
CategoryPropertyValue
ATTRIBUTESAVAILABLE_STRENGTH194 MG / 227 MG / 33 MG
ATTRIBUTESGENERAL_CARDINALITYMULTI
ATTRIBUTESHUMAN_DRUGUS
ATTRIBUTESPRESCRIBABLEY
ATTRIBUTESRXNAV_HUMAN_DRUGUS
ATTRIBUTESSCHEDULE0
ATTRIBUTESTTYSBD
CODESMMSL_CODEBD36925
CODESMMSL_CODEBD4578
CODESRxCUI1101754
CODESSPL_SET_IDf879e8c7-1983-4a85-b87d-38f5068351fc
NAMESPrescribable SynonymVanquish 227 MG / 194 MG / 33 MG Oral Tablet
NAMESRXNAV_STRAPAP 194 MG / ASA 227 MG / Caffeine 33 MG Oral Tablet [Vanquish]
NAMESRxNorm Nameacetaminophen 194 MG / aspirin 227 MG / caffeine 33 MG Oral Tablet [Vanquish]
NAMESRxNorm SynonymAPAP 194 MG / ASA 227 MG / Caffeine 33 MG Oral Tablet [Vanquish]
NAMESRxNorm SynonymVanquish (APAP 194 MG / ASA 227 MG / caffeine 33 MG) Oral Tablet
SOURCESSourceGold Standard Alchemy
SOURCESSourceMetathesaurus FDA Structured Product Labels
SOURCESSourceMicromedex RED BOOK
SOURCESSourceMultum MediSource Lexicon